Core Viewpoint - Jiangsu Jicui Yaokang Biotechnology Co., Ltd. (referred to as "Yaokang Bio") is partially exiting its investment in Jiangxi Zhonghong Boyuan Biotechnology Co., Ltd. through a directed capital reduction, returning an investment of RMB 10 million and receiving a corresponding compensation for fund occupation at an annual interest rate of 5% [2][3]. Summary by Sections 1. Overview of Related Transactions - As of the announcement date, Yaokang Bio has invested RMB 70 million in Jiangxi Zhonghong, holding 22.8261% of its shares. The company will reduce its investment through a directed capital reduction, receiving RMB 10 million back and adjusting its shareholding to 20.2247% [4][10]. - If Jiangxi Zhonghong agrees to allow other shareholders to also reduce their investments by a total of RMB 15 million, Yaokang Bio's shareholding will adjust to 20.9302% [4][10]. 2. Related Party Information - Jiangxi Zhonghong is classified as a related party due to Yaokang Bio's shareholding [6]. 3. Transaction Pricing - The historical total investment by Yaokang Bio is RMB 70 million, and the capital reduction of RMB 10 million corresponds to a shareholding reduction of 2.6014% [10]. - The compensation for fund occupation is calculated to be RMB 1,657,534.25, based on the formula provided [10][12]. 4. Necessity and Impact of the Transaction - The transaction aligns with the overall development strategy and operational plans of the company, and it is not expected to negatively impact the financial status or operational results of Yaokang Bio [21]. 5. Review Procedures - The independent directors and the audit committee have approved the transaction, confirming that the pricing is fair and does not harm the interests of other shareholders [22][23][24].

Group 1 - The company, Hubei Broadcasting and Television Information Network Co., Ltd., signed a capital increase agreement with Hubei Cultural Investment Co., Ltd. to invest 268 million RMB for a 51% stake in Hubei Taizihu Cultural Digital Creative Industry Park Investment Co., Ltd. [1] - Following the initial investment, the company signed a supplementary agreement to invest an additional 20.06 million RMB in December 2020, increasing its stake in Hubei Cultural Investment to 16.67% after a total investment of 288 million RMB [1] Group 2 - The company received a notification from Hubei Broadcasting Station regarding the transfer of equity in Chutian Network, leading to a proposed signing of a directed reduction agreement with Hubei Cultural Investment [2] - The board of directors approved the proposal for the directed reduction agreement, which constitutes a related party transaction but does not qualify as a major asset restructuring under the relevant regulations [2]

Group 1 - The company approved a loan agreement for its subsidiary Zhejiang Bona to borrow up to RMB 40 million from its associate Shanghai Tingdong for business development [1][2] - A supplementary loan agreement was signed, consolidating the RMB 40 million loan with another RMB 30 million loan to Beijing Bona, totaling RMB 70 million for a directed capital reduction repayment plan [2] - The capital reduction will decrease the company's equity stake in Shanghai Tingdong from 9.55% to 4.61% after a total capital reduction of RMB 70.96 million [2][3] Group 2 - The capital reduction is based on an asset valuation report from Beijing Dongshun Asset Appraisal Co., which assessed Shanghai Tingdong's equity value at RMB 132.3 million, reflecting a 96.53% increase from its book value of RMB 67.317 million [10] - The transaction does not constitute a major asset restructuring and does not require shareholder approval [3][10] - The board of directors believes this capital reduction will optimize the financial structure of the subsidiary without significantly impacting the company's financial status or the interests of shareholders, especially minority shareholders [18][19] Group 3 - The independent directors unanimously approved the capital reduction and related transactions, confirming that it would not adversely affect the company's financial condition or independence [19] - The company has had a total of RMB 70 million in loans to the associate Shanghai Tingdong since the beginning of the year [18] - The company will hold a temporary shareholders' meeting on January 5, 2026, to discuss the proposed changes and other matters [49][50]

Group 1 - The company held its 15th meeting of the 6th Board of Directors on July 15, 2025, with all 9 directors present, and the meeting complied with relevant laws and regulations [2][3] - The Board approved the termination of the Jiangshan high-efficiency photovoltaic cell and large-size silicon wafer slicing project, with a unanimous vote of 9 in favor [3] - The company will sign a termination agreement with the Jiangshan Economic Development Zone Management Committee and Jiangshan Economic Development Zone Construction Investment Group [3][15] Group 2 - The Board also approved a proposal for the joint venture company to repurchase equity and reduce capital, with 7 votes in favor and 2 abstentions [4] - The repurchase involves the complete buyback of the equity held by the Xilian Fund, which had a total subscribed capital of 800 million yuan, with the exit price set at approximately 85.87 million yuan [4][34] - The independent directors unanimously agreed to the proposal, confirming that it would not harm the interests of the company or its shareholders [35][55] Group 3 - The company plans to hold its second extraordinary general meeting of 2025 on July 31, 2025, at 15:00, combining on-site voting with online voting [7][8] - The meeting will discuss the proposals approved by the Board, ensuring compliance with legal and regulatory requirements [63][64] - Shareholders can register for the meeting from July 28, 2025, and the registration process is outlined in the announcement [63][64]